NOI - Sole Source ICP OES.doc
DOC document 55 KB Posted
- Solicitation number
- 1228721
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
FDA-Sole Source-128261
| Document Type: |
| Notice of Intent to Sole Source |
| Solicitation Number: |
| FDA - Sole Source - 1228721 |
| Posted Date: |
| 07/01/2020 |
| Response Date: |
| 07/10/2020 |
Intends to make a sole source award:
The Food and Drug Administration (FDA) Center for Food Safety and Nutrition (CFSAN) requires purchasing an (ICS-OES) Agilent 5900 SVDV Inductively coupled plasma optical emission spectrometer. The award will be made to:
Agilent 2850 Centerville Road Willington, DE 19808 In accordance with FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The Center for Food Safety and Nutrition (CFSAN) requires purchasing a Inductively coupled plasma optical emission spectrometer.
The purchase of an Agilent 5900 SVDV (ICP-OES) instrument is critical to support the Agency’s mission in the development and validation of quantitative analytical methods for research and regulatory use. The proposed ICP-OES instrument will assist in the determination of toxic and essential elements in food samples and dietary supplements. Rapid and accurate analysis of toxic and nutrient elements is of utmost importance and the ICP-OES instrument provides unique capability for the analysis of the major and some trace elements at reduced cost compared to Inductively coupled plasma mass spectrometry.
Agilent is the only manufacturer that makes the 5900 SVDV (ICP-OES) Inductively coupled plasma optical emission spectrometer.
This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement within twelve (12) days after the publication of this synopsis which shall be considered by the agency. Responses received after 12 days or without the required information may not be considered. For information concerning this acquisition contact:
Tara Hobson
Contract Specialist Email: Tara.Hobson@fda.hhs.gov No phone calls please A determination by the Government not to compete because of information received is solely within the discretion of the Government. Information received will normally be considered solely for determining whether to conduct a competitive procurement.
1 | Page
File details come from the government source that posted it. Updated .